New developments in the treatment of depression

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 14, 1999, Pages 10-15

  Montgomery, Stuart A ^a,b  

^a Imperial College of Medicine   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE; PINDOLOL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; META ANALYSIS; PRIORITY JOURNAL;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLINICAL TRIALS; DEPRESSIVE DISORDER; FLUOXETINE; HUMANS; MIANSERIN; PLACEBOS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0032863310     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Lepine J-P, Gastpar M, Mendlewicz J, et al. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 1997;12:19-30
2. Guelfi JD, White C, Hackett D, et al. Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. J Clin Psychiatry 1995;56:450-458
3. Rudolph RL, Fabre LF, Feighner J, et al. Randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. J Clin Psychiatry 1998;59:116-122
4. Benkert O, Grunder G, Welzel H, et al. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. J Psychiatr Res 1996;30: 441-452
5. Benkert O, Szegedi A, Kohnen R. Rapid onset of therapeutic action in major depression: a comparative trial of mirtazapine and paroxetine. In: Scientific Abstracts of the 37th Annual Meeting of the American College of Neuropsychopharmacology: Dec 14-18, 1998; Las Croabas, Puerto Rico:311
6. Agren H, Leinonen E, Scarstein J, et al., and the Nordic Antidepressant Study Group. Efficacy and tolerability of mirtazapine vs citalopram: a double-blind, randomized study in patients with major depressive disorder. In: Scientific Abstracts of the 37th Annual Meeting of the American College of Neuropsychopharmacology: Dec 14-18, 1998; Las Croabas. Puerto Rico:320
7. Blier P, Bergeron R. Use of pindolol to potentiate antidepressant medication. J Clin Psychiatry 1998;59(suppl 5):16-23
8. Perez V, Gilaberte I, Faries D, et al. Randomised, double-blind placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 1997;349:1594-1597
9. Berman RM, Darnell AM, Miller HL, et al. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 1997;154:37-43
10. Tome de la Granja MB, Isaak MT, Harte R, et al. Paroxetine and pindolol: a randomised trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int Clin Psychopharmacol 1997;12:81-90
11. Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine: a controlled multicenter study. Psychopharmacol 1986;90:131-138
12. Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990;18:289-299
13. van Moffaert M, de Wilde J, Vereecken A, et al. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression. Int Clin Psychopharmacol 1995;10:3-9
14. Wheatley DP, van Moffaert M, Timmerman L, et al. Mirtazapine efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe depressive disorder. J Clin Psychiatry 1998;59:306-312
15. Clerc GE, Ruimy P, Verdeau-Pailles J. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clir Psychopharmacol 1994;9:139-143
16. Lecrubier Y, Bourin M, Moon CAL, et al. Efficacy of venlafaxine in depressive illness in general practice. Acta Psychiatr Scand 1997;95:485-493
17. Lopez-Ibor J, Guelfi JD, Pletan Y, et al. Milnacipran and selective serotonin reuptake inhibitors in major depression. Int Clin Psychopharmacol 1996;11 (suppl 4):41-46
18. Guelfi JD, Ansseau M, Corruble E, et al. A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients. Int Clin Psychopharmacol 1998;13:121-128
19. Montgomery SA, Reimitz P-E, Zivkov M. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study. Int Clin Psychopharmacol 1998;13:63-73
20. Shrivastava RK, Cohn C, Crowder J, et al. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Psychopharmacol 1994;14:322-329